The HDL particle composition determines its antitumor activity in pancreatic cancer

Despite enormous efforts to improve therapeutic options, pancreatic cancer remains a fatal disease and is expected to become the second leading cause of cancer-related deaths in the next decade. Previous research identified lipid metabolic pathways to be highly enriched in pancreatic ductal adenocar...

Descripción completa

Detalles Bibliográficos
Autores principales: Oberle, Raimund, Kührer, Kristina, Österreicher, Tamina, Weber, Florian, Steinbauer, Stefanie, Udonta, Florian, Wroblewski, Mark, Ben-Batalla, Isabel, Hassl, Ingrid, Körbelin, Jakob, Unseld, Matthias, Jauhiainen, Matti, Plochberger, Birgit, Röhrl, Clemens, Hengstschläger, Markus, Loges, Sonja, Stangl, Herbert
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Life Science Alliance LLC 2022
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9112193/
https://www.ncbi.nlm.nih.gov/pubmed/35577388
http://dx.doi.org/10.26508/lsa.202101317

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9112193/
https://www.ncbi.nlm.nih.gov/pubmed/35577388
http://dx.doi.org/10.26508/lsa.202101317

Ejemplares similares